Nothing really and that is the issue. NP is too timid to run that company. They did say they could put out interim data now and go to fda with it and it would be good, but wants to enroll the last few people and get interim data is 2 weeks. How about use what you have before all the other companies working on treatments use up all the emotional buying. Sounds like GNBT. It’s becoming too late.